LifeStance Health Group (NASDAQ:LFST) Hits New 1-Year Low – What’s Next?

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST) hit a new 52-week low on Monday . The stock traded as low as $4.42 and last traded at $4.49, with a volume of 145403 shares. The stock had previously closed at $4.51.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Canaccord Genuity Group initiated coverage on shares of LifeStance Health Group in a report on Thursday, April 3rd. They set a “buy” rating and a $8.00 price objective for the company. KeyCorp initiated coverage on shares of LifeStance Health Group in a research report on Tuesday, April 8th. They issued an “overweight” rating and a $9.00 price target on the stock. Finally, UBS Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $8.50 price target on the stock in a research report on Tuesday, May 27th. One equities research analyst has rated the stock with a sell rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, LifeStance Health Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $8.50.

LifeStance Health Group Stock Performance

The stock has a market capitalization of $1.71 billion, a P/E ratio of -44.00 and a beta of 1.16. The company’s 50-day moving average is $5.37 and its two-hundred day moving average is $6.64. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 0.19.

Insiders Place Their Bets

In related news, insider Ujjwal Ramtekkar sold 16,000 shares of LifeStance Health Group stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $5.94, for a total value of $95,040.00. Following the sale, the insider directly owned 113,435 shares in the company, valued at $673,803.90. This trade represents a 12.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 6.60% of the stock is currently owned by corporate insiders.

Institutional Trading of LifeStance Health Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Parcion Private Wealth LLC acquired a new position in shares of LifeStance Health Group in the 1st quarter worth approximately $15,670,000. Dimensional Fund Advisors LP increased its position in shares of LifeStance Health Group by 87.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company’s stock worth $25,977,000 after acquiring an additional 1,643,390 shares in the last quarter. Jacobs Levy Equity Management Inc. purchased a new position in shares of LifeStance Health Group in the first quarter worth approximately $7,932,000. Nuveen LLC purchased a new position in shares of LifeStance Health Group in the first quarter worth approximately $6,928,000. Finally, Vanguard Group Inc. increased its position in shares of LifeStance Health Group by 7.9% in the fourth quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company’s stock worth $78,781,000 after acquiring an additional 784,818 shares in the last quarter. 85.50% of the stock is currently owned by institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.